Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
What We Do
Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
About Vantage
Editorial team
Products & Services
Consensus Forecasts
Pharma
EvaluatePharma
EvaluatePharma Vision
Custom Solutions
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Client Success
Customer Testimonials
Thought Leadership
English
日本語
About Us
Media Centre
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Policy & Pricing
Policy & Regulation
Pricing
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Inovio Pharmaceuticals
November 15, 2017
SITC – Oncosec heats up tumours, and so might competition
October 26, 2017
SITC preview – All eyes on Incyte and Infinity
October 12, 2016
Transgene pins hopes on cancer vaccine combos
August 15, 2016
Therapy focus – Hepatitis B developers try to repeat Gilead’s hep C trick
August 04, 2016
Inovio gets the final farewell from Roche
August 14, 2015
Immuno-oncology collaborations enliven 2015’s dog days
August 10, 2015
Vaccines lead charge in cervical cancer
September 22, 2014
Still unpartnered, but now worth a lot more
January 08, 2014
Small cap biotechs reap rewards of the bull market in 2013
January 03, 2014
Pharma business development news over Christmas
November 27, 2013
Immuno-oncology buzz awakens Roche’s interest in cancer vaccines
Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
December 17, 2019
Vantage 2020 Preview
July 31, 2019
Vantage Pharma, Biotech & Medtech Half-Year Review 2019
Editor's Picks
January 09, 2020
What makes a great year for takeovers?
January 07, 2020
Surprise! There’s a tumour in which Keytruda doesn’t work
December 19, 2019
Gene therapy clinical holds take centre stage
December 20, 2019
Plenty of choice remains for buyers of gene therapy
October 14, 2019
Uncovering biopharma’s hidden treasures
